Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi takes $250M hit after J&J E. coli vaccine fails in ph. 3
A year and a half after Sanofi swooped on Johnson & Johnson’s dismantled vaccines unit to pick up an E. coli candidate, the asset failed its trial.
James Waldron
Feb 13, 2025 4:14am
Sanofi cuts programs tied to multibillion-dollar deals
Jan 30, 2025 9:05am
Atalanta loads crossbow with $97M, 2 Big Pharmas in tow
Jan 28, 2025 7:00am
FDA pulls diversity guidance for clinical trials from website
Jan 27, 2025 11:00am
Sanofi inks $400M biobucks deal for Alloy's antisense platform
Jan 8, 2025 5:08am
I-Mab pauses Sanofi-partnered prospect to focus on CLDN18.2
Jan 6, 2025 8:34am